AstraZeneca on Friday came out to defend their Covid-19 vaccine, reiterating that there was “no evidence of an increased risk” of blood clots.
According to them, the vaccine roll-outs should continue since no evidence has been confirmed linking the blood clots and the vaccine.
Denmark had on Thursday suspended AstraZeneca Covid-19 vaccine after several cases of blood clots were reported amongst those who received the jab.
A Danish person was one of the people who experienced the clot although the authority did not confirm whether there was a link between the Oxford University developed vaccine and the blood clots. As a result, the country has stopped using the vaccine for 14 days as it investigates.
Thailand’s Prime Minister, Prayut Chan-o-cha, cancelled plans to publicly get the AstraZeneca as the country also delayed the roll-outs plans.
According to the European Medicines Agency, the number of thromboembolic cases on Monday amongst individuals that got vaccinated was not higher than in the general population.
- US City To Dim Lights To Protect Birds From Crashing And Dying
- Pevert Ladies Who Fought For Eric Omondi Arrested
- REVEALED: How The Late Tecra Spoilt Omar Lali With Millions Of Money
- Third Degree Murder Added Against The Police Who Killed George Floyd
- Amason Kingi Dumps Raila, Says He Is Tired Of Being A Squatter In ODM
In the meantime, the European Medicines Agency confirmed that Latvia, Lithuania, Luxembourg and Estonia had temporarily stopped the vaccine usage after Austria. The batch was delivered to 17 European countries including Denmark.
“Both we and the Danish Medicines Agency have to respond to reports of possible serious side-effects, both from Denmark and other European countries,” the Danish Health Authority’s director Soren Brostrom said in a statement.